Testicular orphan nuclear receptor 4-associated protein 16 promotes non-small cell lung carcinoma by activating estrogen receptor β and blocking testicular orphan nuclear receptor 2

Fang,Fang; Zheng,Qingfeng; Zhang,Jianzhi; Dong,Bin; Zhu,Sainan; Huang,Xiaoyun; Wang,Yang; Zhao,Bingtian; Li,Shaolei; Xiong,Hongchao; Chen,Jinfeng; Wu,Nan; Song,Sonya  Wei; Chang,Chawnshang; Yang,Yue

doi:10.3892/or.2012.2107

January 2013 Volume 29 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

January 2013 Volume 29 Issue 1

Full Size Image

Article

Testicular orphan nuclear receptor 4-associated protein 16 promotes non-small cell lung carcinoma by activating estrogen receptor β and blocking testicular orphan nuclear receptor 2

Authors:
- Fang Fang
- Qingfeng Zheng
- Jianzhi Zhang
- Bin Dong
- Sainan Zhu
- Xiaoyun Huang
- Yang Wang
- Bingtian Zhao
- Shaolei Li
- Hongchao Xiong
- Jinfeng Chen
- Nan Wu
- Sonya Wei Song
- Chawnshang Chang
- Yue Yang
View Affiliations / Copyright

Affiliations: Department of Thoracic Surgery Ⅱ, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, P.R. China, Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, P.R. China, Department of Medical Statistics, Peking University First Hospital, Beijing 100034, P.R. China, Department of Clinical Research Laboratory, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, P.R. China, Departments of Pathology, Urology, Radiation Oncology, and Cancer Center, George Whipple Laboratory for Cancer Research, University of Rochester Medical Center, Rochester, NY 14642, USA
Pages: 297-305
|
Published online on: October 26, 2012

https://doi.org/10.3892/or.2012.2107
Expand metrics +

Abstract

The possible involvement of estrogen receptors (ERs) and testicular orphan nuclear receptors (TRs) in human non-small cell lung carcinoma (NSCLC) has been suggested, but their precise roles and their relationship remain largely unknown. This study aimed to investigate whether TR4-associated protein 16 (TRA16) regulates the ERβ and TR2 pathways and could be a potential target in NSCLC. We used tissue microarrays including NSCLC tissues (n=154) and negative controls (n=14) to examine the expression of TRA16 and ERβ, and in vitro reporter gene assays, the mammalian two-hybrid method and immunoprecipitation in Cos-1 cells to investigate the relationships among TRA16, ERβ and TR2. We found that TRA16 was highly expressed in approximately 90% of the NSCLC tissues examined. TRA16 overexpression was significantly associated with TNM stage, tumor size, lymph node metastasis, tumor thrombus in vein, tumor differentiation and prognosis of NSCLC patients, in which TRA16 was shown to be an independent prognostic factor. Introduction of TRA16 into Cos-1 cells enhanced cell proliferation. Co-expression of TRA16 and ERβ in Cos-1 cells using different reporter gene systems and mammalian two-hybrid approaches revealed that TRA16 enhanced ERβ-mediated transcriptional activity. By adopting similar approaches, and immunoprecipitation and immunocytofluorescence assays, we found that TRA16 also interacted with TR2, and blocked the TR2 inhibitory effect on ERβ. Our findings demonstrate that TRA16 could be a promising diagnostic and prognostic biomarker in NSCLC, and promotes cancer cell growth through activation of the ERβ pathway by interacting with ERβ and TR2.

View Figures

View References

1	Siegel R, Ward E, Brawley O and Jemal A: Global Cancer Statistics, 2011 The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
2	Kawai H, Ishii A, Washiya K, Konno T, Kon H, Yamaya C, Ono I, Minamiya Y and Ogawa J: Estrogen receptor α and β are prognostic factors in non-small cell lung cancer. Clin Cancer Res. 11:5084–5089. 2005.
3	Schwartz AG, Prysak GM, Murphy V, Lonardo F, Pass H, Schwartz J and Brooks S: Nuclear estrogen receptor β in lung cancer: expression and survival differences by sex. Clin Cancer Res. 11:7280–7287. 2005.
4	Siegfried JM, Hershberger PA and Stabile LP: Estrogen receptor signaling in lung cancer. Semin Oncol. 36:524–534. 2005. View Article : Google Scholar
5	Mollerup S, Jørgensen K, Berge G and Haugen A: Expression of estrogen receptors α and β in human lung tissue and cell lines. Lung Cancer. 37:153–159. 2002.
6	Omoto Y, Kobayashi Y, Nishida K, Tsuchiya E, Eguchi H, Nakagawa K, Ishikawa Y, Yamori T, Iwase H, Fujii Y, Warner M, Gustafsson JA and Hayashi S: Expression, function, and clinical implications of the estrogen receptor β in human lung cancers. Biochem Biophys Res Commun. 285:340–347. 2001.
7	Patrone C, Cassel T, Pettersscon K, Piao Y, Piao Y, Cheng G, Ciana P, Maggi A, Warner M, Gustafsson J and Nord M: Regulation of postnatal lung development and homeostasis by estrogen receptor β. Mol Cell Biol. 23:8542–8552. 2003.
8	Niikawa H, Suzuki T, Miki Y, Suzuki S, Nagasaki S, Akahira J, Honma S, Evans DB, Hayashi S, Kondo T and Sasano H: Intratumoral estrogens and estrogen receptors in human non small cell lung carcinoma. Clin Cancer Res. 14:4417–4426. 2008. View Article : Google Scholar : PubMed/NCBI
9	Mah V, Seligson D, Li A, Marquez D, Wistuba I, Elshimali Y, Fishbein M, Chia D, Pietras R and Goodglick L: Aromatase expression predicts survival in women with early-stage non-small cell lung cancer. Cancer Res. 21:10484–10490. 2007. View Article : Google Scholar : PubMed/NCBI
10	Weinberg O, Marquez-Garban D, Fishbein M, Goodglick L, Garban H, Dubinett S and Pietras R: Aromatase inhibitors in human lung cancer therapy. Cancer Res. 24:11287–11291. 2005. View Article : Google Scholar : PubMed/NCBI
11	Stabile L, Gaither Davis A, Gubish C, Hopkins T, Luketich J, Christie N, Finkelstein S and Siegfried J: Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor α and β and show biological responses to estrogen. Cancer Res. 62:2141–2150. 2002.
12	Chang C, Kokontis J and Liao ST: Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science. 240:324–326. 1988. View Article : Google Scholar : PubMed/NCBI
13	Evans RM: The steroid and thyroid hormone receptor superfamily. Science. 240:889–895. 1988. View Article : Google Scholar : PubMed/NCBI
14	Beato M: Gene regulation by steroid hormones. Cell. 56:335–344. 1989. View Article : Google Scholar : PubMed/NCBI
15	Wang LH, Tsai SY, Cook RG, Beattie WG, Tsai MJ and O'Malley BW: Coup transcription factor is a member of the steroid receptor superfamily. Nature. 340:163–166. 1989. View Article : Google Scholar : PubMed/NCBI
16	Tsai MJ and O'Malley BW: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem. 63:451–486. 1994. View Article : Google Scholar : PubMed/NCBI
17	Shyr CR, Hu YC, Kim E and Chang C: Modulation of estrogen receptor-mediated transactivation by orphan receptor TR4 in MCF-7 cells. J Biol Chem. 277:14622–14628. 2002. View Article : Google Scholar : PubMed/NCBI
18	Yang Y, Wang X, Dong T, Kim E, Lin WJ and Chang C: Identification of a novel testicular orphan receptor-4(TR4)-associated protein as repressor for the selective suppression of TR4-mediated transactivation. J Biol Chem. 278:7709–7717. 2003. View Article : Google Scholar : PubMed/NCBI
19	Shyr CR, Kang HY, Tsai MY, Liu NC, Ku PY, Huang KE and Chang C: Roles of testicular orphan nuclear receptors 2 and 4 in early embryonic development and embryonic stem cells. Endocrinology. 150:2454–2462. 2009. View Article : Google Scholar : PubMed/NCBI
20	Hu YC, Shyr CR, Che W, Mux M, Kim E and Chang C: Suppression of estrogen receptor-mediated transcription and cell growth by interaction with TR2 orphan receptor. J Biol Chem. 277:33571–33579. 2002. View Article : Google Scholar : PubMed/NCBI
21	Kononen J, Bubendorf L, Kallionimeni A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G and Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 4:844–847. 1998. View Article : Google Scholar : PubMed/NCBI
22	Zheng QF, Dong B, Sun Y, Du H, Xiong HC, Wu N, Chen JF, Sun L, Ao J, Li JY, Ji JF and Yang Y: Expression of TR4-associated protein in non-small cell lung cancer. Beijing Daxuexue Bao. 39:472–475. 2007.(in Chinese).
23	Schneider J, Velcovsky HG, Morr H, Katz N, Neu K and Eigenbrodt E: Comparison of the tumor markers tumor M2-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancer. Anticancer Res. 20:5053–5058. 2000.PubMed/NCBI
24	Salgia R, Harpole D, Herndon JE II, Pisick E, Elias A and Skarin AT: Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer. Anticancer Res. 21:1241–1246. 2001.PubMed/NCBI
25	Iggo R, Gatter K, Bartek J, Lane D and Harris AL: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet. 335:675–679. 1990. View Article : Google Scholar : PubMed/NCBI
26	Mulshine JL and Sullivan DC: Clinical practice. Lung cancer screening. N Engl J Med. 352:2714–2720. 2005. View Article : Google Scholar : PubMed/NCBI
27	Ishibashi H, Suzuki T, Suzuki S, Niikawa H, Lu L, Miki Y, Moriya T, Hayashi S, Handa M, Kondo T and Sasano H: Progesterone receptor in non-small cell lung cancer - A potent prognostic factor and possible target for endocrine therapy. Cancer Res. 65:6450–6458. 2005. View Article : Google Scholar : PubMed/NCBI
28	Beattie CW, Hansen NW and Thomas PA: Steroid receptors in human lung cancer. Cancer Res. 45:4206–4214. 1985.PubMed/NCBI
29	Stabie L and Siegfried J: Estrogen receptor pathways in lung cancer. Curr Oncol Rep. 6:259–267. 2004. View Article : Google Scholar
30	Villa E, Colantoni A, Grottola A, Ferretti I, Buttafoco P, Bertani H, De Maria ND and Manenti F: Variant estrogen receptors and their role in liver disease. Mol Cell Endocrinol. 193:65–69. 2002. View Article : Google Scholar : PubMed/NCBI
31	Hershberger P, Vasquez A, Kanterewicz B, Land S, Siegfried J and Nichols M: Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res. 65:1598–1605. 2005. View Article : Google Scholar : PubMed/NCBI